Rosuvastatin prescribing information |
|
 |
|
Ann Thorac Surg. 2009 Nov;88(5):1440-4.
Hata M, Takayama T, Sezai A, Yoshitake I, Hirayama A, Minami K.
Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan.
Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease.
Intern Med. 2009;48(21):1869-73. Epub 2009 Nov 2.
Kanazawa I, Yamaguchi T, Yamauchi M, Sugimoto T.
Department of Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.
Eur J Pharmacol. 2009 Oct 30. [Epub ahead of print]
Choi EY, Chang W, Lim S, Song BW, Cha MJ, Kim HJ, Choi E, Jang Y, Chung N, Hwang KC.
Cardiology Division, Yonsei Cardiovascular Center, Yonsei University Health System, Seoul, 120-752, Republic of Korea.
Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of G(h).
Eur J Heart Fail. 2009 Nov 4. [Epub ahead of print]
Tsutamoto T, Yamaji M, Kawahara C, Nishiyama K, Fujii M, Yamamoto T, Horie M.
Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Seta-Tsukinowa, Otsu 520-2192, Japan.
Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.
Rosuvastatin review article...
|
|
Antilipemic agents
 Rosuvastatin prescribing information
Buy here
|
|
My Basket
